Obesity and assisted reproduction

Česká verzia

Authors: M. Maděrka
Authors place of work: Repromeda s. r. o., Brno
Published in the journal: Ceska Gynekol 2023; 88(3): 200-208
Category:
doi: https://doi.org/10.48095/cccg2023200

Summary

The World Health Organization defines obesity as an abnormal or excessive accumulation of fat that is harmful to health. Obesity and overweight have a negative effect not only on general health, but also on reproductive health. Obesity is associated with reduced fertility, more frequent pregnancy losses and other pregnancy complications. Due to an obesity pandemic, an increasing proportion of women seeking medical help for infertility will be overweight or obese. Obesity is involved in the pathogenesis of polycystic ovary syndrome (PCOS), approximately 40–70% of PCOS patients are overweight or obese. The risk of miscarriage is increased in obese women who become pregnant after in vitro fertilisation, regardless of whether their own oocytes or donated oocytes are used. In men, the link between obesity and reduced fertility is less well-studied than in women. Mechanisms by which obesity may affect spermatogenesis include thermal effects, hyperestrogenism, hypogonadotropic hypogonadism, diabetes mellitus, sexual dysfunction, and sperm epigenetic disorders. Obesity in both women and men negatively affects the results of assisted reproduction. Overweight or obese women should be informed about the overall health and obstetric risks and about the lower success rate of infertility treatment with assisted reproduction methods.

Keywords:

obesity – assisted reproduction – overweight – infertility – Polycystic ovary syndrome – In vitro fertilization

Zdroje

1. Vandevijvere S, Chow CC, Hall KD et al. Increased food energy supply as a major driver of the obesity epidemic: a global analysis. Bull World Health Organ 2015; 93 (7): 446–456. doi: 10.2471/BLT.14.150565.

2. Aune D, Sen A, Prasad M et al. BMI and all cause mortality: systematic review and non--linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ 2016; 353: i2156. doi: 10.1136/bmj.i2156.

3. Calle EE, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348 (17): 1625–1638. doi: 10.1056/NEJMoa021423.

4. Fontaine KR, Redden DT, Wang C et al. Years of life lost due to obesity. JAMA 2003; 289 (2): 187–193. doi: 10.1001/jama.289.2.187.

5. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecolo 1935; 29 (2): 181–191. doi: 10.1016/S0002-9378 (15) 30642-6.

6. Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG 2006; 113 (10): 1148–1159. doi: 10.1111/j.1471-0528.2006. 00990.x.

7. Pasquali R, Gambineri A. Metabolic effects of obesity on reproduction. Reprod Biomed Online 2006; 12 (5): 542–551. doi: 10.1016/s1472-6483 (10) 61179-0.

8. Pasquali R, Pelusi C, Genghini S et al. Obesity and reproductive disorders in women. Hum Reprod Update 2003; 9 (4): 359–372. doi: 10.1093/humupd/dmg024.

9. Jain A, Polotsky AJ, Rochester D et al. Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women. J Clin Endocrinol Metab 2007; 92 (7): 2468–2473. doi: 10.1210/jc.2006-2274.

10. Castillo-Martínez L, López-Alvarenga JC, Villa AR et al. Menstrual cycle length disorders in 18- to 40-y-old obese women. Nutrition 2003; 19 (4): 317–320. doi: 10.1016/s0899-9007 (02) 00998-x.

11. Polotsky AJ, Hailpern SM, Skurnick JH et al. Association of adolescent obesity and lifetime nulliparity – the Study of Women’s Health Across the Nation (SWAN). Fertil Steril 2010; 93 (6): 2004–2011. doi: 10.1016/j.fertnstert.2008.12.059.

12. Bellver J, Rossal LP, Bosch E et al. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril 2003; 79 (5): 1136–1140. doi: 10.1016/s0015-0282 (03) 00176-6.

13. Weir CB, Jan A. BMI classification percentile and cut off points. In: StatPearls 2022. Treasure Island (FL): StatPearls Publishing 2023.

14. Gillett WR, Putt T, Farquhar CM. Prioritising for fertility treatments – the effect of excluding women with a high body mass index. BJOG 2006; 113 (10): 1218–1221. doi: 10.1111/j.1471-0528. 2006.00995.x.

15. Awartani KA, Nahas S, Al Hassan SH et al. Infertility treatment outcome in sub groups of obese population. Reprod Biol Endocrinol 2009; 7: 52. doi: 10.1186/1477-7827-7-52.

16. Zachariah M, Fleming R, Acharya U. Management of obese women in assisted conception units: a UK survey. Hum Fertil (Camb) 2006; 9 (2): 101–105. doi: 10.1080/14647270500475214.

17. Luke B, Brown MB, Stern JE et al. Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates. Hum Reprod 2011; 26 (1): 245–252. doi: 10.1093/humrep/deq306.

18. Yildiz BO, Knochenhauer ES, Azziz R. Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab 2008; 93 (1): 162–168. doi: 10.1210/jc.2007-1834.

19. Carmina E, Bucchieri S, Esposito A et al. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab 2007; 92 (7): 2500–2505. doi: 10.1210/jc.2006-2725.

20. Panidis D, Macut D, Tziomalos K et al. Prevalence of metabolic syndrome in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2013; 78 (4): 586–592. doi: 10.1111/cen.12008.

21. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005; 352 (12): 1223–1236. doi: 10.1056/NEJMra041536.

22. Balen AH, Conway GS, Kaltsas G et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995; 10 (8): 2107–2111. doi: 10.1093/oxfordjournals.humrep.a136243.

23. Norman RJ, Masters SC, Hague W et al. Metabolic approaches to the subclassification of polycystic ovary syndrome. Fertil Steril 1995; 63 (2): 329–335.

24. Georgopoulos NA, Saltamavros AD, Vervita V et al. Basal metabolic rate is decreased in women with polycystic ovary syndrome and biochemical hyperandrogenemia and is associated with insulin resistance. Fertil Steril 2009; 92 (1): 250–255. doi: 10.1016/j.fertnstert.2008.04.067.

25. Hirschberg AL, Naessén S, Stridsberg M et al. Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome. Gynecol Endocrinol 2004; 19 (2): 79–87. doi: 10.1080/09513590400002300.

26. Moran LJ, Noakes M, Clifton PM et al. Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. J Clin Endocrinol Metab 2004; 89 (7): 3337–3344. doi: 10.1210/ jc.2003-031583.

27. Alviggi C, Conforti A, De Rosa P et al. The distribution of stroma and antral follicles differs between insulin-resistance and hyperandrogenism-related polycystic ovarian syndrome. Front Endocrinol (Lausanne) 2017; 8: 117. doi: 10.3389/fendo.2017.00117.

28. Dapas M, Lin FT, Nadkarni GN et al. Distinct subtypes of polycystic ovary syndrome with novel genetic associations: an unsupervised, phenotypic clustering analysis. PLoS Med 2020; 17 (6): e1003132. doi: 10.1371/journal.pmed.1003132.

29. Hartz AJ, Barboriak PN, Wong A et al. The association of obesity with infertility and related menstural abnormalities in women. Int J Obes 1979; 3 (1): 57–73.

30. Nestler JE, Stovall D, Akhter N et al. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril 2002; 77 (2): 209–215. doi: 10.1016/s0015-0282 (01) 02963-6.

31. Budak E, Fernández Sánchez M, Bellver J et al. Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. Fertil Steril 2006; 85 (6): 1563–1581. doi: 10.1016/j.fertnstert.2005.09.065.

32. Gosman GG, Katcher HI, Legro RS. Obesity and the role of gut and adipose hormones in female reproduction. Hum Reprod Update 2006; 12 (5): 585–601. doi: 10.1093/humupd/dml024.

33. Moschos S, Chan JL, Mantzoros CS. Leptin and reproduction: a review. Fertil Steril 2002; 77 (3): 433–444. doi: 10.1016/s0015-0282 (01) 03010-2.

34. Cozzolino M, García-Velasco JA, Meseguer M et al. Female obesity increases the risk of miscarriage of euploid embryos. Fertil Steril 2021; 115 (6): 1495–1502. doi: 10.1016/j.fertnstert.2020.09.139.

35. Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod 2004; 19 (7): 1644–1646. doi: 10.1093/humrep/deh277.

36. Metwally M, Saravelos SH, Ledger WL et al. Body mass index and risk of miscarriage in women with recurrent miscarriage. Fertil Steril 2010; 94 (1): 290–295. doi: 10.1016/j.fertn- stert.2009.03.021.

37. Provost MP, Acharya KS, Acharya CR et al. Pregnancy outcomes decline with increasing body mass index: analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008–2010 Society for Assisted Reproductive Technology registry. Fertil Steril 2016; 105 (3): 663–669. doi: 10.1016/j.fertnstert.2015.11.008.

38. Dickey RP, Taylor SN, Curole DN et al. Relationship of clomiphene dose and patient weight to successful treatment. Hum Reprod 1997; 12 (3): 449–453. doi: 10.1093/humrep/12.3.449.

39. Loh S, Wang JX, Matthews CD. The influence of body mass index, basal FSH and age on the response to gonadotrophin stimulation in non-polycystic ovarian syndrome patients. Hum Reprod 2002; 17 (5): 1207–1211. doi: 10.1093/humrep/17.5.1207.

40. Páez JC, Arreseygor VG, Zgrablich P. Obesity and the possibility of conceiving a child during assisted reproduction treatment: an Argentinian experience. JBRA Assist Reprod 2020; 24 (2): 115–117. doi: 10.5935/1518-0557.20190064.

41. Koning AM, Mutsaerts MA, Kuchenbecker WK et al. Complications and outcome of assisted reproduction technologies in overweight and obese women. Hum Reprod 2012; 27 (2): 457–467. doi: 10.1093/humrep/der416.

42. Fullston T, Ohlsson Teague EM et al. Paternal obesity initiates metabolic disturbances in two generations of mice with incomplete penetrance to the F2 generation and alters the transcriptional profile of testis and sperm microRNA content. FASEB J 2013; 27 (10): 4226–4243. doi: 10.1096/fj.12-224048.

43. McPherson NO, Fullston T, Bakos HW et al. Obese father’s metabolic state, adiposity, and reproductive capacity indicate son’s reproductive health. Fertil Steril 2014; 101 (3): 865–873. doi: 10.1016/j.fertnstert.2013.12.007.

44. Soubry A, Schildkraut JM, Murtha A at al. Paternal obesity is associated with IGF2 hypomethylation in newborns: results from a Newborn Epigenetics Study (NEST) cohort. BMC Med 2013; 11: 29. doi: 10.1186/1741-7015-11-29.

45. Pasquali R. Obesity and androgens: facts and perspectives. Fertil Steril 2006; 85 (5): 1319–1340. doi: 10.1016/j.fertnstert.2005.10.054.

46. Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org, Practice Committee of the American Society for Reproductive Medicine. Obesity and reproduction: a committee opinion. Fertil Steril 2021; 116 (5): 1266–1285. doi: 10.1016/j.fertnstert.2021.08.018.

47. Jensen TK, Andersson AM, Jørgensen N et al. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril 2004; 82 (4): 863–870. doi: 10.1016/j.fertnstert.2004.03.056.

48. Du Plessis SS, Cabler S, McAlister DA et al. The effect of obesity on sperm disorders and male infertility. Nat Rev Urol 2010; 7 (3): 153–161. doi: 10.1038/nrurol.2010.6.

49. Aggerholm AS, Thulstrup AM, Toft G et al. Is overweight a risk factor for reduced semen quality and altered serum sex hormone profile? Fertil Steril 2008; 90 (3): 619–626. doi: 10.1016/ j.fertnstert.2007.07.1292.

50. Chavarro JE, Toth TL, Wright DL et al. Body mass index in relation to semen quality, sperm DNA integrity, and serum reproductive hormone levels among men attending an infertility clinic. Fertil Steril 2010; 93 (7): 2222–2231. doi: 10.1016/j.fertnstert.2009.01.100.

51. Duits FH, van Wely M, van der Veen F et al. Healthy overweight male partners of subfertile couples should not worry about their semen quality. Fertil Steril 2010; 94 (4): 1356–1359. doi: 10.1016/j.fertnstert.2009.05.075.

52. Eskandar M, Al-Asmari M, Babu Chaduvula S et al. Impact of male obesity on semen quality and serum sex hormones. Adv Urol 2012; 2012: 407601. doi: 10.1155/2012/407601.

53. Macdonald AA, Stewart AW, Farquhar CM. Body mass index in relation to semen quality and reproductive hormones in New Zealand men: a cross-sectional study in fertility clinics. Hum Reprod 2013; 28 (12): 3178–3187. doi: 10.1093/humrep/det379.

54. Campbell JM, Lane M, Owens JA et al. Paternal obesity negatively affects male fertility and assisted reproduction outcomes: a systematic review and meta-analysis. Reprod Biomed Online 2015; 31 (5): 593–604. doi: 10.1016/ j.rbmo.2015.07.012.

55. Dupont C, Faure C, Sermondade N et al. Obesity leads to higher risk of sperm DNA damage in infertile patients. Asian J Androl 2013; 15 (5): 622–625. doi: 10.1038/aja.2013.65.

56. Fariello RM, Pariz JR, Spaine DM et al. Association between obesity and alteration of sperm DNA integrity and mitochondrial activity. BJU Int 2012; 110 (6): 863–867. doi: 10.1111/j.1464-410X.2011.10813.x.

57. Bandel I, Bungum M, Richtoff J et al. No association between body mass index and sperm DNA integrity. Hum Reprod 2015; 30 (7): 1704–1713. doi: 10.1093/humrep/dev111.

58. Eisenberg ML, Kim S, Chen Z et al. The relationship between male BMI and waist circumference on semen quality: data from the LIFE study. Hum Reprod 2014; 29 (2): 193–200. doi: 10.1093/humrep/det428.

59. Rybar R, Kopecka V, Prinosilova P et al. Male obesity and age in relationship to semen parameters and sperm chromatin integrity. Andrologia 2011; 43 (4): 286–291. doi: 10.1111/j.1439-02 72.2010.01057.x.

60. Ramlau-Hansen CH, Thulstrup AM, Nohr EA et al. Subfecundity in overweight and obese couples. Hum Reprod 2007; 22 (6): 1634–1637. doi: 10.1093/humrep/dem035.

61. Kolotkin RL, Zunker C, Østbye T. Sexual functioning and obesity: a review. Obesity (Silver Spring) 2012; 20 (12): 2325–2333. doi: 10.1038/ oby.2012.104.

62. Han TS, Tajar A, O’Neill TW et al. Impaired quality of life and sexual function in overweight and obese men: the European Male Ageing Study. Eur J Endocrinol 2011; 164 (6): 1003–1011. doi: 10.1530/EJE-10-1129.

63. Burnett AL, Strong TD, Trock BJ et al. Biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction. J Urol 2009; 181 (1): 245–251. doi: 10.1016/j.juro.2008.09.005.

64. Araña Rosaínz M de J, Ojeda MO, Acosta JR et al. Imbalanced low-grade inflammation and endothelial activation in patients with type 2 diabetes mellitus and erectile dysfunction. J Sex Med 2011; 8 (7): 2017–2030. doi: 10.1111/j.1743-6109.2011.02277.x.

65. Kelleher S, Conway AJ, Handelsman DJ. Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 2004; 89 (8): 3813–3817. doi: 10.1210/jc.2004-0143.

66. Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289 (1): 76–79. doi: 10.1001/jama.289.1.76.

67. Eisenberg ML, Sundaram R, Maisog J et al. Diabetes, medical comorbidities and couple fecundity. Hum Reprod 2016; 31: 2369–2376. doi: 10.1093/humrep/dew200.

68. Luboshitzky R, Lavie L, Shen-Orr Z et al. Altered luteinizing hormone and testosterone secretion in middle-aged obese men with obstructive sleep apnea. Obes Res 2005; 13 (4): 780–786. doi: 10.1038/oby.2005.88.

69. Luboshitzky R, Zabari Z, Shen-Orr Z at al. Disruption of the nocturnal testosterone rhythm by sleep fragmentation in normal men. J Clin Endocrinol Metab 2001; 86 (3): 1134–1139. doi: 10.1210/jcem.86.3.7296.

70. Torres M, Laguna-Barraza R, Dalmases M et al. Male fertility is reduced by chronic intermittent hypoxia mimicking sleep apnea in mice. Sleep 2014; 37 (11): 1757–1765. doi: 10.5665/sleep.4166.

71. Magnusdottir EV, Thorsteinsson T, Thorsteins- dottir S et al. Persistent organochlorines, sedentary occupation, obesity and human male subfertility. Hum Reprod 2005; 20 (1): 208–215. doi: 10.1093/humrep/deh569.

72. Oliva A, Spira A, Multigner L. Contribution of environmental factors to the risk of male infertility. Hum Reprod 2001; 16 (8): 1768–1776. doi: 10.1093/humrep/16.8.1768.

73. Shafik A, Olfat S. Lipectomy in the treatment of scrotal lipomatosis. Br J Urol 1981; 53 (1): 55–61. doi: 10.1111/j.1464-410x.1981.tb031 29.x.

74. Jung A, Schill WB. Male infertility. Current life style could be responsible for infertility. MMW Fortschr Med 2000; 142 (37): 31–33.

75. Rajender S, Avery K, Agarwal A. Epigenetics, spermatogenesis and male infertility. Mutat Res 2011; 727 (3): 62–71. doi: 10.1016/j.mrrev.2011.04.002.

76. Nilsson EE, Skinner MK. Environmentally induced epigenetic transgenerational inheritance of disease susceptibility. Transl Res 2015; 165 (1): 12–17. doi: 10.1016/j.trsl.2014.02.003.

77. Soubry A, Schildkraut JM, Murtha A et al. Paternal obesity is associated with IGF2 hypomethylation in newborns: results from a Newborn Epigenetics Study (NEST) cohort. BMC Med 2013; 11: 29. doi: 10.1186/1741-7015-11-29.

78. Huber-Buchholz MM, Carey DG, Norman RJ. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 1999; 84 (4): 1470–1474. doi: 10.1210/jcem.84.4. 5596.

79. Balen AH, Anderson RA. Impact of obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines. Hum Fertil (Camb) 2007; 10 (4): 195–206. doi: 10.1080/14647270701731290.

80. Bates GW, Whitworth NS. Effect of body weight reduction on plasma androgens in obese, infertile women. Fertil Steril 1982; 38 (4): 406–409.

81. Garrow JS, Summerbell CD. Meta-analysis: effect of exercise, with or without dieting, on the body composition of overweight subjects. Eur J Clin Nutr 1995; 49 (1): 1–10.

82. Skender ML, Goodrick GK, Del Junco DJ et al. Comparison of 2-year weight loss trends in behavioral treatments of obesity: diet, exercise, and combination interventions. J Am Diet Assoc 1996; 96 (4): 342–346. doi: 10.1016/S0002-822 3 (96) 00096-X.

83. Zain MM, Norman RJ. Impact of obesity on female fertility and fertility treatment. Womens Health (Lond) 2008; 4 (2): 183–194. doi: 10.2217/17455057.4.2.183.

84. Henness S, Perry CM. Orlistat: a review of its use in the management of obesity. Drugs 2006; 66 (12): 1625–1656. doi: 10.2165/00003495-20 0666120-00012.

85. Astrup A, Rössner S, Van Gaal L et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 2009; 374 (9701): 1606–1616. doi: 10.1016/S0140-6736 (09) 61375-1.

86. Peirson L, Douketis J, Ciliska D et al. Treatment for overweight and obesity in adult populations: a systematic review and meta-analysis. CMAJ Open 2014; 2 (4): E306–E317. doi: 10.9778/cmajo.20140012.

87. Salameh JR. Bariatric surgery: past and present. Am J Med Sci 2006; 331 (4): 194–200. doi: 10.1097/00000441-200604000-00005.

88. Eid GM, Cottam DR, Velcu LM et al. Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass. Surg Obes Relat Dis 2005; 1 (2): 77–80. doi: 10.1016/ j.soard.2005.02.008.

89. Teitelman M, Grotegut CA, Williams NN et al. The impact of bariatric surgery on menstrual patterns. Obes Surg 2006; 16 (11): 1457–1463. doi: 10.1381/096089206778870148.

90. Andreasen LA, Nilas L, Kjær MM. Operative complications during pregnancy after gastric bypass – a register-based cohort study. Obes Surg 2014; 24 (10): 1634–1638. doi: 10.1007/ s11695-014-1232-z.

91. Beard JH, Bell RL, Duffy AJ. Reproductive considerations and pregnancy after bariatric surgery: current evidence and recommendations. Obes Surg 2008; 18 (8): 1023–1027. doi: 10.1007/s11695-007-9389-3.

92. Monson M, Jackson M. Pregnancy after bariatric surgery. Clin Obstet Gynecol 2016; 59 (1): 158–171. doi: 10.1097/GRF.0000000000000178.

93. American Dietetic Association, American Society of Nutrition, Siega-Riz AM, King JC. Position of the American Dietetic Association and American Society for Nutrition: obesity, reproduction, and pregnancy outcomes. J Am Diet Assoc 2009; 109 (5): 918–927. doi: 10.1016/ j.jada.2009.03.020.

94. Sheiner E, Edri A, Balaban E et al. Pregnancy outcome of patients who conceive during or after the first year following bariatric surgery. Am J Obstet Gynecol 2011; 204 (1): 50.e1–50.e6. doi: 10.1016/j.ajog.2010.08.027.

95. Kjaer SK, van den Brule AJ, Paull G et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow-up study. BMJ 2002; 325 (7364): 572. doi: 10.1136/bmj.325.7364.572.

96. Metwally M, Cutting R, Tipton A et al. Effect of increased body mass index on oocyte and embryo quality in IVF patients. Reprod Biomed Online 2007; 15 (5): 532–538. doi: 10.1016/s1472-6483 (10) 60385-9.

97. Bellver J, Rossal LP, Bosch E et al. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril 2003; 79 (5): 1136–1140. doi: 10.1016/s0015-0282 (03) 00176-6.

98. Bellver J, Melo MA, Bosch E et al. Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil Steril 2007; 88 (2): 446–451. doi: 10.1016/j.fertnstert.2006.11.162.

99. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259 (5091): 87–91. doi: 10.1126/science.7678183.

100. Cnattingius S, Bergström R, Lipworth L et al. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 1998; 338 (3): 147–152. doi: 10.1056/NEJM199801153380302.

101. Catov JM, Bodnar LM, Kip KE et al. Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol 2007; 197 (6): 610.e1–610.e7. doi: 10.1016/ j.ajog.2007.04.024.

102. Catov JM, Bodnar LM, Ness RB et al. Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol 2007; 166 (11): 1312–1319. doi: 10.1093/aje/kwm 273.